Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

Raymond Y. Huang; Wenya Linda Bi; Michael Weller; Thomas Kaley; Jaishri Blakeley; Ian Dunn; Evanthia Galanis; Matthias Preusser; Michael McDermott; Leland Rogers; Jeffrey Raizer; David Schiff; Riccardo Soffietti; Jörg Christian Tonn; Michael Vogelbaum; Damien Weber; David A. Reardon; Patrick Y. Wen

doi:10.1093/NEUONC/NOY137

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

Raymond Y. Huang, Wenya Linda Bi, Michael Weller, Thomas Kaley, Jaishri Blakeley, Ian Dunn, Evanthia Galanis, Matthias Preusser, Michael McDermott, Leland Rogers, Jeffrey Raizer, David Schiff, Riccardo Soffietti, Jörg Christian Tonn, Michael Vogelbaum, Damien Weber, David A. Reardon, Patrick Y. Wen

Miami Neuroscience Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	21
DOIs	https://doi.org/10.1093/NEUONC/NOY137
State	Published - Jan 1 2019

Disciplines

Critical Care
Medicine and Health Sciences

Access to Document

10.1093/NEUONC/NOY137License: Unspecified

Cite this

Huang, R. Y., Bi, W. L., Weller, M., Kaley, T., Blakeley, J., Dunn, I., Galanis, E., Preusser, M., McDermott, M., Rogers, L., Raizer, J., Schiff, D., Soffietti, R., Tonn, J. C., Vogelbaum, M., Weber, D., Reardon, D. A., & Wen, P. Y. (2019). Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group. Neuro-oncology, 21. https://doi.org/10.1093/NEUONC/NOY137

Huang, RY, Bi, WL, Weller, M, Kaley, T, Blakeley, J, Dunn, I, Galanis, E, Preusser, M, McDermott, M, Rogers, L, Raizer, J, Schiff, D, Soffietti, R, Tonn, JC, Vogelbaum, M, Weber, D, Reardon, DA & Wen, PY 2019, 'Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group', Neuro-oncology, vol. 21. https://doi.org/10.1093/NEUONC/NOY137

@article{4a9b37c50dbe49e28e804f286d942c83,

title = "Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group",

author = "Huang, \{Raymond Y.\} and Bi, \{Wenya Linda\} and Michael Weller and Thomas Kaley and Jaishri Blakeley and Ian Dunn and Evanthia Galanis and Matthias Preusser and Michael McDermott and Leland Rogers and Jeffrey Raizer and David Schiff and Riccardo Soffietti and Tonn, \{J{\"o}rg Christian\} and Michael Vogelbaum and Damien Weber and Reardon, \{David A.\} and Wen, \{Patrick Y.\}",

note = "No standard criteria exist for assessing response and progression in clinical trials involving patients with meningioma, and there is no consensus on the optimal endpoints for trials currently under way. As a result, there is substantial variation in the design and response criteria of meningioma trials, making comparison between trials difficult.",

year = "2019",

month = jan,

day = "1",

doi = "10.1093/NEUONC/NOY137",

language = "American English",

volume = "21",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

AU - Huang, Raymond Y.

AU - Bi, Wenya Linda

AU - Weller, Michael

AU - Kaley, Thomas

AU - Blakeley, Jaishri

AU - Dunn, Ian

AU - Galanis, Evanthia

AU - Preusser, Matthias

AU - McDermott, Michael

AU - Rogers, Leland

AU - Raizer, Jeffrey

AU - Schiff, David

AU - Soffietti, Riccardo

AU - Tonn, Jörg Christian

AU - Vogelbaum, Michael

AU - Weber, Damien

AU - Reardon, David A.

AU - Wen, Patrick Y.

N1 - No standard criteria exist for assessing response and progression in clinical trials involving patients with meningioma, and there is no consensus on the optimal endpoints for trials currently under way. As a result, there is substantial variation in the design and response criteria of meningioma trials, making comparison between trials difficult.

PY - 2019/1/1

Y1 - 2019/1/1

UR - https://academic.oup.com/neuro-oncology/article/21/1/26/5076187

U2 - 10.1093/NEUONC/NOY137

DO - 10.1093/NEUONC/NOY137

M3 - Article

VL - 21

JO - Neuro-oncology

JF - Neuro-oncology

ER -

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

Disciplines

Access to Document

Other files and links

Cite this